Screener
BioRestorative Therapies BRTX Q2 2025 earnings
Reported August 12, 2025 · After market close
Revenue$303.3KBeat by $103.3K
EPS-$0.30Beat by $0.11
Revenue estimate$200.0K
EPS estimate-$0.41
Next report
Sep 22, 2026 (In 4 days)Revenue estimate$600.0K
EPS estimate-$2.00
Versus estimates
Revenue
Diluted EPS
FAQ
- When did BioRestorative Therapies report Q2 2025 earnings?
- BioRestorative Therapies (BRTX) reported Q2 2025 earnings on August 12, 2025 after market close.
- What were BioRestorative Therapies's Q2 2025 revenue and EPS?
- BioRestorative Therapies reported revenue of $303.3K and eps of $-0.30 for Q2 2025.
- Did BioRestorative Therapies beat estimates in Q2 2025?
- Revenue beat the consensus estimate of $200.0K by $103.3K. EPS beat the consensus estimate of $-0.41 by $0.11.
- How did BioRestorative Therapies's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 240.4% from $89.1K a year earlier and eps grew 40.0% from $-0.50.
- Where can I find BioRestorative Therapies's Q2 2025 SEC filings?
- You can read the 8-K earnings release (0001021771-25-000113) and the 10-Q periodic report (0001641172-25-023211) directly on SEC EDGAR. The filing index links above go to sec.gov.
